A patient-gene model for temporal expression profiles in clinical studies.
Pharmacogenomics and clinical studies that measure the temporal expression levels of patients can identify important pathways and biomarkers that are activated during disease progression or in response to treatment. However, researchers face a number of challenges when trying to combine expression profiles from these patients. Unlike studies that rely on lab animals or cell lines, individuals vary in their baseline expression and in their response rate. In this paper we present a generative model for such data. Our model represents patient expression data using two levels, a gene level, which corresponds to a common response pattern, and a patient level, which accounts for the patient specific expression patterns and response rate. Using an EM algorithm, we infer the parameters of the model. We used our algorithm to analyze multiple sclerosis patient response to interferon-beta. As we show, our algorithm was able to improve upon prior methods for combining patients data. In addition, our algorithm was able to correctly identify patient specific response patterns.
Kaminski
Naftali
N
Simmons Center for Interstitial Lung Disease, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania, USA.
Bar-Joseph
Ziv
Z
D000465:Algorithms; D002454:Cell Differentiation; D020869:Gene Expression Profiling; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008957:Models, Genetic; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy*; D018482:Muscle, Skeletal / Q000166:cytology; D020411:Oligonucleotide Array Sequence Analysis; D010597:Pharmacogenetics; D015003:Yeasts / Q000166:cytology
D016899:Interferon-beta